May 14, 2018 / 8:08 PM / in 9 days

BRIEF-Mersana Therapeutics Reports Q1 Loss Per Share $0.54

May 14 (Reuters) - Mersana Therapeutics Inc:

* MERSANA THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

* Q1 LOSS PER SHARE $0.54

* Q1 EARNINGS PER SHARE VIEW $-0.61 — THOMSON REUTERS I/B/E/S

* COLLABORATION REVENUE FOR Q1 2018 WAS APPROXIMATELY $3.1 MILLION, COMPARED TO $4.3 MILLION

* Q1 REVENUE VIEW $3.7 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below